The product does NOT contain any epitope tags. The protein has a calculated MW of 17.4 kDa. The protein migrates as 18 kDa on a SDS-PAGE gel under reducing (R) condition.
>95% as determined by reduced SDS-PAGE.
>95% as determined by SEC-MALS.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Biotinylated Human TNF-alpha, epitope tag free, primary amine labeling (active trimer) (MALS verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Biotinylated Human TNF-alpha, epitope tag free, primary amine labeling (active trimer) (MALS verified) (Cat. No. TNA-H8211) was more than 95% in HP-SEC, and the molecular weight of this protein is around 48-65 kDa verified by SEC-MALS.
Immobilized Humira at 5 μg/mL (100 μL/well) can bind Biotinylated Human TNF-alpha, epitope tag free, primary amine labeling (active trimer) (MALS verified) (Cat. No. TNA-H8211) with a linear range of 0.4-6 ng/mL (QC tested).
Authors: Gao R, et al
Journal: Opt Express 2020
Application: cross activity
Authors: M El Amrani, et al
Journal: Journal of Translational Autoimmunity 2019
Authors: D Lebert, et al
Journal: US20190011455A1 2019
Application: Affinity chromatography
Authors: Lebert Dorothée, et al
Journal: US20180321253A1 2018
Application: Mass Spectrometry ImmunoAffinity
Authors: Yu Bo, et al.
Journal: US20180313834A1 2018
Application: Flow Cytometry
Authors: P Sabhachandani, et al.
Journal: Microchim Acta 2015
Application: Microsphere-based assay
Authors: B Yu, et al.
Journal: US20140155285A1 2014
Application: Antibody Screening by FACS
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Emerging VoCs, Lambda, Delta, Beta, Alpha mutants and so on, including RBD, S trimer, S1, NTD, NP, etc. These mutants are of high purity and bioactivity and can be used to evaluate the efficacy of the antibodies and vaccination.
ELISA kits for neutralizing antibody titer assay, binding antibody titer assay, antibody isotype assay, antigen titer assay and inhibitor screening, etc., which can accelerate the research and development of anti-SARS-CoV-2 drugs and vaccines.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2， CD133, GPRC5D，CCR8, CCR5, etc.
This web search service is supported by Google Inc.